AK PHARMA INC. – Trademark Portfolio

Entity Type: 03

AK PHARMA INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EIKONHA, RELIXIN, AK PHARMA, and SKININ ADVANCED MICRONEEDLING SYSTEM. The owner is based in PLEASANTVILLE, NJ.

P. O. BOX 111

PLEASANTVILLE, NJ 08232

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AK PHARMA INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does AK PHARMA INC. have?

AK PHARMA INC. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 2 cancelled.

What trademark classes does AK PHARMA INC. file in?

AK PHARMA INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AK PHARMA INC.'s most well-known trademarks?

AK PHARMA INC.'s registered trademark portfolio includes well-known marks such as EIKONHA, RELIXIN, AK PHARMA, and SKININ ADVANCED MICRONEEDLING SYSTEM. These are among 4 currently registered trademarks in the portfolio.

What is AK PHARMA INC.'s trademark registration success rate?

AK PHARMA INC. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.